Glenmark Pharma receives USFDA approval for sodium phenylbutyrate tablets | Tech Reddy
[ad_1] Glenmark Pharmaceuticals Limited has received final approval from the United States Food and Drug Administration (US FDA) for Sodium Phenylbutyrate Tablets USP, 500 mg, Generic Version Buphenyl Tablets, 500 mg, Horizon Therapeutics, LLC. According to the filings, Glenmark’s Sodium Phenylbutyrate Tablets USP, 500 mg, is distributed in the USA by Glenmark Pharmaceuticals Inc., USA. … Read more